Does the “delayed start” protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial

[1]  R. Davar,et al.  Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: An RCT , 2018, International journal of reproductive biomedicine.

[2]  K. Yang,et al.  Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization , 2017, Obstetrics & gynecology science.

[3]  H. Yarali,et al.  Live birth rates in various subgroups of poor ovarian responders fulfilling the Bologna criteria. , 2017, Reproductive biomedicine online.

[4]  A. Aflatoonian,et al.  Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study , 2017, International journal of reproductive biomedicine.

[5]  A. Maged,et al.  Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase , 2015, Reproductive Sciences.

[6]  P. Patrizio,et al.  How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. , 2015, Reproductive biomedicine online.

[7]  J. Zhao,et al.  Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. , 2014, Reproductive biomedicine online.

[8]  L. Rienzi,et al.  Management of Poor Responders in IVF: Is There Anything New? , 2014, BioMed research international.

[9]  M. Cedars,et al.  A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders. , 2014, Fertility and sterility.

[10]  Ying-pu Sun,et al.  Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria. , 2014, International journal of clinical and experimental medicine.

[11]  S. Daneshmand,et al.  Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. , 2011, Fertility and sterility.

[12]  P. Haentjens,et al.  Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. , 2011, Fertility and sterility.

[13]  I. Izhaki,et al.  Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles. , 2010, Fertility and sterility.

[14]  H. Taylor,et al.  GnRH antagonists may affect endometrial receptivity. , 2008, Fertility and sterility.

[15]  N. Frydman,et al.  Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. , 2003, Human reproduction.

[16]  K Lundin,et al.  Human embryos with unevenly sized blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and multinucleation. , 2001, Human reproduction.

[17]  W. Schoolcraft,et al.  Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. , 2000, Fertility and sterility.

[18]  B. Fauser,et al.  Manipulation of human ovarian function: physiological concepts and clinical consequences. , 1997, Endocrine reviews.

[19]  M. Eijkemans,et al.  The poor responder in IVF: is the prognosis always poor?: a systematic review. , 2012, Human reproduction update.